ChemoCentryx
CCXI
#3596
Rank
C$5.19 B
Marketcap
C$72.23
Share price
0.00%
Change (1 day)
30.68%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): C-$2.40

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is C-$2.63. In 2021 the company made an earnings per share (EPS) of C-$2.63 a decrease over its 2020 EPS that were of C-$1.13.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)C-$2.40-8.64%
2021C-$2.63133.33%
2020C-$1.13-16.49%
2019C-$1.3527.63%
2018C-$1.06-305.41%
2017C$0.51-142.53%
2016C-$1.21-19.44%
2015C-$1.50-0%
2014C-$1.5013.68%
2013C-$1.32-16.67%
2012C-$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.48-689.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.89-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.32-226.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.91-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.27-567.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.16-486.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.81-283.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.24-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.72-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel